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FIG. 1. Schematic representation of normal and osteo-
arthritic subchondral bone osteoblasts. Compared to
normal, osteoarthritic cells showed a decreased cAMP
response to PTH and PGE2, and increased 1,25(OH)2D3
response levels of alkaline phosphatase (ALPase) and
osteocalcin; basal IGF-1 and urokinase (uPA) were also
enhanced.ALTHOUGH major progress has been made in the last
few years, there is still much to learn about the
etiology, pathogenesis and progression of osteo-
arthritis (OA). This disease can be described as
the degradation and loss of articular cartilage
accompanied by hypertrophic bone changes with
osteophyte formation and subchondral plate
thickening.
Subchondral bone sclerosis is a well-recognized
manifestation of human OA; however, the mech-
anisms responsible are unknown. Two theories are
currently proposed. The mechanical stress on
weight-bearing joints may contribute to increase
in microfractures in the bone plate and overlaying
cartilage. As articular cartilage slowly erodes,
sclerosis of the subchondral bone plate also
progresses and bone sti#ness increases in this
tissue, possibly contributing to further mechanical
disturbances of the cartilage. On the other hand,
changes in the subchondral bone such as sclerosis
may precede cartilage damage in OA. A steep
sti#ness gradient in the underlying subchondral
bone may therefore be an initiation mechanism of
OA as the integrity of the overlying articular
cartilage depends on the mechanical properties of
its bony bed.
The mechanisms responsible for subchondral
bone sclerosis in OA have not yet been elucidated,
and whether these mechanisms reflect a cellular
defect of osteoblasts or an adaptation to local
and/or systemic factors is undetermined. We there-
fore undertook a study [1] in which we initially
evaluated the phenotypic behavior of subchondral
bone osteoblasts from OA and normal individuals
by examining specific biomarkers. Data showed
(Fig. 1) a phenotypic change in the cyclic adenos-
ine monophosphate (cAMP) production of OA
subchondral bone osteoblasts in response to
parathyroid hormone (PTH) and prostaglandin
(PGE ), and an alteration of alkaline phosphataseand osteocalcin when these diseased cells were
treated with vitamin D (1,25(OH)2D3).
Local, systemic and/or mechanical factors may
also contribute to the modulation of bone density
in this disease. We hypothesized that the abnormal
osteoblasts from subchondral bone in human OA
occurs due to an increased activity of growth
factors and proteases present locally. More pre-
cisely, we postulated that two major systems are
involved in this process, the insulin-like growth
factor (IGF)-1 and plasminogen activator (PA)/
plasmin systems as both can promote osteoblast
cell growth directly or indirectly.
Our general hypothesis is as follows. At the
onset or during the OA process, a thickening of the
underlying subchondral bone is noted. This could
result from repetitive loading, microfracture
and/or the activity of the IGF/IGF binding protein
(IGFBP) system leading to an abnormal response
of the subchondral bone. This in turn creates local
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matrix damage. This cartilage damage is normally
repaired by either local synthesis or the release of
IGF/IGFBP that stimulates matrix formation in
the cartilage. At the same time, the IGF system
promotes bone cell growth and bone matrix depo-
sition. The anabolic activity of the IGF-1 system
which can be locally regulated by the PA/plasmin
system is enhanced in subchondral bone, while the
local activation of the PA/plasmin system in carti-
lage promotes local cartilage alteration. Thus, the
local induction in bone and cartilage of IGF-1 and
its protease regulatory system promotes both car-
tilage damage and subchondral bone plate thick-
ening, this last pathway leading to further
cartilage damage. This imbalance in the repair
capacity and damage of cartilage due to subchon-
dral plate thickening subsequently leads to a pro-
gressively altered cartilage matrix and eventually
to OA, hence, explaining the slow progression of
the disease.
Indeed, results showed (1) that OA sub-
chondral bone osteoblasts produce elevated levelsof both IGF-1 and urokinase plasminogen acti-
vator (uPA), and that the level of the specific
uPA inhibitor plasminogen activator inhibitor
(PAI)-1 does not significantly di#er between OA
and normal subchondral bone osteoblasts. More-
over, preliminary experiments suggest that IGF-1
may stimulate the basal uPA activity. According
to our theory, this causes an increase in bone
formation thereby promoting a greater bone
sti#ness.
Data from our study strongly support the
concept that a bone defect may contribute to the
onset and/or progression of cartilage degradation
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